ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

5,656Medicare Part D Prescriptions Filled, Including Refills

Rank: 174 out of 337

$770K Total Retail Price of All Prescriptions

Rank: 24 out of 337

194 Patients Receiving at Least One Drug in Part D
29%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 194 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

21% of this provider’s 194 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 2,144 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$136 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
OMEPRAZOLE 265 71 1 4
LOVASTATIN 207 86 2 24
METFORMIN HCL 196 80 3 12
SIMVASTATIN 194 110 4 1
LISINOPRIL 169 71 5 2
HYDROCODONE-ACETAMINOPHEN 129 57 S3 6 13
PROAIR HFA 128 44 7 38
ALENDRONATE SODIUM 125 101 8 19
AMLODIPINE BESYLATE 108 64 9 3
LEVOTHYROXINE SODIUM 103 43 10 5
HYDROCHLOROTHIAZIDE 102 65 11 9
FLUTICASONE PROPIONATE 95 38 12 34
RANITIDINE HCL 94 14 13 30
ATORVASTATIN CALCIUM 90 16 14 7
GLIPIZIDE ER 78 27 15 69
FUROSEMIDE 78 31 15 8
ATENOLOL 76 16 17 10
ZOLPIDEM TARTRATE 76 33 17 23
METOPROLOL TARTRATE 76 50 17 6
CITALOPRAM HBR 74 26 20 17
CYCLOBENZAPRINE HCL 74 15 R 20 103
IBUPROFEN 72 28 22 64
NEXIUM 70 25 23 56
ADVAIR DISKUS 69 32 24 44
PANTOPRAZOLE SODIUM 69 18 24 36
FENOFIBRATE 68 34 26 48
GLIPIZIDE 65 36 27 45
LANTUS 63 25 28 49
SPIRIVA 57 34 29 43
INSULIN SYRINGE 54 14 30 127
QUINAPRIL HCL 52 43 31 50
WARFARIN SODIUM 50 25 32 11
LANTUS SOLOSTAR 50 14 32 146
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 5, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.